Back to Blog

New York Lawmaker Fights for Decriminalization of Psilocybin Mushrooms

May 17, 2021
Legislation
SageBrains arrow right button

Known as “magic mushrooms,” Psilocybin has been making its way through the medical world. Now it may be on its way towards decriminalization in New York.

In 2018, the United States Food and Drug Administration founded the use of Psilocybin as  "breakthrough therapy for treatment-resistant depression.” Now, New York lawmakers have stuck their ground in wanting to decriminalize Psilocybin as it’s paving a new way in psychedelic therapy.

Psilocybin’s Potential to Treat Mental Health Conditions

The natural chemical compound found in Psilocybin has been proven to help depression, OCD, and even nicotine addiction. In a John Hopkins study, they tested out the effects of Psilocybin on adults with major depression.

They found that after taking two doses of Psilocybin under supportive psychotherapy, the surveyed adult’s, depression levels reduced in just under two weeks. The speed of treatment is not only a game-changer, but it outlines the potential of psychedelic therapy.  

As discussed in the blog, we have seen various studies done in the US to determine Psilocybin’s effects on adults with major depression. Studies found the impacts of Psilocybin not only helped adults with depression but also other mental health conditions.

Clinical Trials of Psilocybin

As Psilocybin has been tested numerous times, we are starting to see from various studies the endless benefits. Not only has it helped adults with depression studies show Psilocybin has benefited those with addiction issues.

A study by John Hopkins in 2014 revealed 80 percent of patients after supportive psychotherapy were nicotine-free. Not only was this a success for those battling nicotine addiction, but John Hopkins launched a Center for Psychedelic and Consciousness Research due to continuous psychedelic research.

Upcoming studies from the Center for Psychedelic and Consciousness Research will introduce the effectiveness of Psilocybin through supportive psychotherapy. Some of the research they will be conducting will be focused on addiction, post-traumatic disorder (PTSD), post-treatment of Lyme disease, and Alzheimer’s.

The Future of Psilocybin-Assisted Therapy

As New York legislatures are trying to decriminalize Psilocybin, multiple cities such as Santa Cruz, CA, Oakland, CA, and Denver, CO all have removed the ban. These cities are paving the way for Psilocybin-Assisted Therapy.

Psilocybin Decriminalization Movement

In 2010, the Psilocybin and Psilocyn decriminalization movement began, but this has been a battle since the 1960s and 1970s when the War on Drugs sprouted. Advocates are hopeful that under Biden and the Democractic Congress, the progression for psychedelic therapy will blossom. Though this is only the start for decriminalization, lobbyists are setting their eyes on the movement and hoping for success.

As research from top trusted medical universities show, Psilocybin is the least of US citizens' problems. Not only is there significant proof of the medical benefits brought by supportive psychotherapy, but lobbyists are now fighting for a chance to decriminalize Psilocybin and Psilocyn.

New York may be the next city in the list where both Psilocybin and Psilocyn are decriminalized. Therefore, it is important for all to be educated and aware of this new therapy, but conscious of the everlasting benefits of psychedelics.

Share with friends!

Start the
journey today.

Join the thousands who are receiving their psychedelic news, clinical trials, research and other information from SageBrains.

Get Started